BusinessCombiMatrix to Present Large-Scale Study Indicating the Severity of Genomic Abnormalities Decreases from Conception to Childhood at the 2nd Congress on Recurrent Pregnancy LossBy Nasdaq OMXJan 20, 2017, 11:00 AM UTC
BusinessCombiMatrix Corporation Reports Third Quarter 2016 Financial and Operating ResultsBy Nasdaq OMXNov 2, 2016, 10:00 AM UTC
BusinessCombiMatrix Corporation to Release 2016 Third Quarter Financial Results on November 2, 2016By Nasdaq OMXOct 26, 2016, 10:00 AM UTC
BusinessCombiMatrix to Present at September Investment ConferencesBy Nasdaq OMXSep 8, 2016, 10:00 AM UTC
BusinessCombiMatrix Announces Distribution Agreement with Universal Diagnostic Laboratories for Miscarriage Analysis TestingBy Nasdaq OMXAug 10, 2016, 10:00 AM UTC
BusinessCombiMatrix Launches Preimplantation Genetic Diagnostic Testing for Single Gene Disorders and Chromosomal TranslocationsBy Nasdaq OMXApr 5, 2016, 10:00 AM UTC
BusinessCombiMatrix Comments on Medical Policy Revisions by Cigna Health and Three BCBS Health Plans to Reimburse for Recurrent Pregnancy Loss TestingBy Nasdaq OMXMar 29, 2016, 10:00 AM UTC
BusinessCombiMatrix Closes $8.0 Million Underwritten Public OfferingBy Nasdaq OMXMar 24, 2016, 1:59 PM UTC
